| Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ... Nature genetics 46 (11), 1166-1169, 2014 | 218 | 2014 |
| The genomic landscape of male breast cancers S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ... Clinical Cancer Research 22 (16), 4045-4056, 2016 | 152 | 2016 |
| MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast S Piscuoglio, M Murray, N Fusco, C Marchiò, FL Loo, LG Martelotto, ... Histopathology 67 (5), 719-729, 2015 | 102 | 2015 |
| PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine? N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, EG Rocco, ... Genes 11 (7), 719, 2020 | 98 | 2020 |
| Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer G Valente, F Morani, G Nicotra, N Fusco, C Peracchio, R Titone, O Alabiso, ... BioMed research international 2014 (1), 462658, 2014 | 97 | 2014 |
| PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer N Fusco, U Malapelle, M Fassan, C Marchiò, S Buglioni, S Zupo, ... Frontiers in Oncology 11, 644737, 2021 | 92 | 2021 |
| MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB–NFIB fusion gene J Kim, FC Geyer, LG Martelotto, CKY Ng, RS Lim, P Selenica, A Li, ... The Journal of pathology 244 (2), 143-150, 2018 | 86 | 2018 |
| HER2 low, ultra-low, and novel complementary biomarkers: expanding the spectrum of HER2 positivity in breast cancer K Venetis, E Crimini, E Sajjadi, C Corti, E Guerini-Rocco, G Viale, ... Frontiers in molecular biosciences 9, 834651, 2022 | 84 | 2022 |
| Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer N Fusco, FC Geyer, MR De Filippo, LG Martelotto, CKY Ng, S Piscuoglio, ... Modern Pathology 29 (11), 1292-1305, 2016 | 83 | 2016 |
| HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions N Fusco, EG Rocco, C Del Conte, C Pellegrini, G Bulfamante, F Di Nuovo, ... Modern Pathology 26 (6), 816-824, 2013 | 78 | 2013 |
| Mismatch repair protein loss as a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability N Fusco, G Lopez, C Corti, C Pesenti, P Colapietro, G Ercoli, G Gaudioso, ... JNCI Cancer Spectrum 2 (4), pky056, 2018 | 77 | 2018 |
| Tackling the diversity of breast cancer related lymphedema: Perspectives on diagnosis, risk assessment, and clinical management A Michelotti, M Invernizzi, G Lopez, D Lorenzini, F Nesa, A De Sire, ... The Breast 44, 15-23, 2019 | 75 | 2019 |
| The role of the pathologist in the next-generation era of tumor molecular characterization V Angerilli, F Galuppini, F Pagni, N Fusco, U Malapelle, M Fassan Diagnostics 11 (2), 339, 2021 | 63 | 2021 |
| The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study E Guerini‐Rocco, Z Hodi, S Piscuoglio, CKY Ng, EA Rakha, ... The Journal of pathology 237 (2), 166-178, 2015 | 62 | 2015 |
| Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations E Guerini‐Rocco, S Piscuoglio, CKY Ng, FC Geyer, MR De Filippo, ... The Journal of pathology 238 (5), 677-688, 2016 | 60 | 2016 |
| Impact of rehabilitation on breast cancer related fatigue: a pilot study M Invernizzi, A De Sire, L Lippi, K Venetis, E Sajjadi, F Gimigliano, ... Frontiers in Oncology 10, 556718, 2020 | 57 | 2020 |
| Targeting immune-related biological processes in solid tumors: we do need biomarkers F Pagni, E Guerini-Rocco, AM Schultheis, G Grazia, E Rijavec, M Ghidini, ... International journal of molecular sciences 20 (21), 5452, 2019 | 56 | 2019 |
| Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study A de Sire, A Baricich, F Renò, C Cisari, N Fusco, M Invernizzi Aging clinical and experimental research 32, 959-962, 2020 | 55 | 2020 |
| Atlas of PD-L1 for pathologists: indications, scores, diagnostic platforms and reporting systems S Marletta, N Fusco, E Munari, C Luchini, A Cimadamore, M Brunelli, ... Journal of Personalized Medicine 12 (7), 1073, 2022 | 50 | 2022 |
| PD-L1 testing and squamous cell carcinoma of the head and neck: a multicenter study on the diagnostic reproducibility of different protocols S Crosta, R Boldorini, F Bono, V Brambilla, E Dainese, N Fusco, ... Cancers 13 (2), 292, 2021 | 50 | 2021 |
elham sajjadi在 unimi.it 的电子邮件经过验证
